Haijieya Launches China's First Tumor Minimally Invasive Innovation Center and Unveils New Product Portfolio

On May 19, the Hygea Innovation Center, established by domestic innovator Hygea, officially commenced operations at the Beijing Satellite Manufacturing Factory Science and Technology Park.

On the day of the Innovation Center’s inauguration, dozens of experts, scholars, and industry professionals in the field of oncologic interventional medicine—including Academicians Teng Gaojun and Ge Junbo, Professor Liu Jing, Professor Fan Weijun, Professor Wang Weidong, and Professor Zou Yinghua—convened in the main lecture hall of the Innovation Center. They engaged in an in-depth academic discussion on cutting-edge topics such as building a clinical-need-driven medical innovation system, the development and future of multimodal combined cryo-thermal ablation technology, and the industry outlook for minimally invasive oncologic interventional techniques.

The Hygea Innovation Center will bring together talent and technological resources from diverse fields to accelerate the deep integration of technology and clinical practice, and to expedite the training of professionals in interventional medicine. As China’s first innovation center centered on minimally invasive interventional oncology, the Hygea Innovation Center provides an academic platform where clinicians and researchers can engage in direct dialogue and collaboration. This enables clinicians to promptly understand and apply the latest scientific achievements, expand application scenarios for new technologies, access more opportunities for clinical trials, and rapidly translate cutting-edge technological advancements into innovative therapeutic approaches in clinical practice.

At the opening ceremony, Hygea also launched three new products: the ELF™ Combined Cryo-Thermal Ablation System, the EXCEED™ Tumor Microwave Therapy System, and the EASYSOLV™ AI Ablation Surgical Planning System.

Hygea Innovation Center, spanning nearly 5,000 square meters, has been transformed from the former final assembly workshop of China’s first artificial satellite, “Dong Fang Hong I.” With its futuristic design and digital-intelligent immersive experiences, it creates a sanctuary of “medical art” amidst light and shadow.

Hygea Innovation Center

It is reported that the Innovation Center was redesigned and renovated by AREP, a world-renowned French design group. This design team has previously led heritage revitalization projects such as Notre-Dame de Paris, the Blue Train Restaurant, and Beijing’s Dashilar area, creating numerous classic examples of architectural adaptive reuse. The current design is themed around “Connecting History, Showcasing the Future.” As the birthplace of Dong Fang Hong I, this site is not only where history was made, but also where dreams are realized and scientific boundaries are pushed.

Luo Fuliang, President of Hygea, introduced that beyond basic functions such as exhibition, research, and office operations, the core mission of this facility is to serve as a frontier for the integration of technology and medicine. By providing deeply immersive experiences that tightly integrate augmented reality (AR) with real-world scenarios, it delivers the most dynamic technological experience to every medical pioneer and innovator in medical engineering. Accelerating the training of clinical talent in oncology is a critical factor determining the quality and standard of future medical practice. To this end, Hygea has established a National Minimally Invasive Oncology Treatment Medical Training Center here, fostering deep multi-party collaboration among industry, academia, research, and clinical practice. This initiative aims to accelerate the development and growth of minimally invasive oncology specialists, thereby promoting the sustainable development of Chinese intelligent manufacturing, Chinese technology, and Chinese minimally invasive techniques.

Luo Fuliang stated that the idea of establishing an innovation center emerged after the birth of the first prototype of Kangbo Knife, Hygea’s domestically pioneering and internationally original composite cryo-thermal ablation product for tumors.

Compared with Europe and the United States, China exhibits a nearly tenfold gap in the penetration rate of minimally invasive interventional oncology. In addition to strengthening our technical workforce and product pipeline, high-quality physician training is a key factor in the widespread adoption of these technologies. The development of this discipline has endowed domestic innovative enterprises with a new mission.

After two years of preparation, Hygea established China's first medical innovation center dedicated to minimally invasive oncology.

The Innovation Center is equipped with three space-grade surgical pods, including a hybrid operating room (DSA + CT), as well as standalone DSA and CT operating rooms. It supports a wide range of minimally invasive interventional oncology procedures, simulation-based device training, ex vivo tissue and organ training, and live animal experiments, integrating medical care, scientific research, education, and academic exchange. By establishing a training base that simulates real-world clinical environments, the center cultivates technical talent for primary-care hospitals and contributes to the advancement of China’s minimally invasive interventional oncology sector.

Surgical Treatment of Tumors Enters the Era of Minimally Invasive Surgery.

Traditional cancer treatments, primarily consisting of surgery, radiotherapy, and pharmacotherapy, often inevitably cause significant harm to the body. In this context, minimally invasive tumor treatment technologies have emerged as a rapidly advancing field. Ablation therapy offers high target specificity, maximizing the preservation of healthy tissue. It boasts advantages such as minimal invasiveness, safety, high operability, good repeatability, and rapid postoperative recovery. Whether used as a curative or palliative approach, ablation therapy has demonstrated favorable efficacy in the comprehensive management of tumors. It is gaining increasing recognition among clinicians and has become one of the most rapidly developing cancer treatment modalities in China.

Among these, green minimally invasive therapies such as combined cryo-thermal ablation are being widely adopted in clinical practice. Hygea’s Combo Knife integrates the advantages of deep cryogenic ablation and high-temperature hyperthermia, achieving a broad therapeutic temperature range from -196°C to 85°C within a single fine probe. This innovation overcomes the limitations of conventional standalone cryoablation or hyperthermia by combining their respective strengths to achieve complete tumor inactivation. Preliminary clinical studies have demonstrated that the Combo Knife procedure not only retains the benefits of traditional cryoablation but also offers the advantages of high-temperature hemostasis and prevention of needle-track seeding, exhibiting favorable safety and efficacy profiles.

With an incision of only about 2 mm and no need for sutures, the ComboKnife offers advantages such as minimal trauma, painlessness, good tolerance, and rapid recovery. These benefits are establishing it as one of the mainstream surgical procedures. Its recent designation as a Breakthrough Device by the U.S. FDA has further underscored its technological edge, making it a quintessential example of China’s original innovations being exported to overseas markets and leading accelerated innovation in the field.

Hygea Unveils the "Yi" Series Combosword™ New Product—ELF™ Hybrid Cryo-Thermal Ablation SystemThe newly launched ELF™ Hybrid Cryo-Thermal Ablation System, part of Hygea’s "Yi" series, represents the 3.5th generation of the Combosword™ platform. It features a 44% reduction in volume and a lightweight design for enhanced portability. Multiple key core components have been optimized; notably, the single ablation treatment channel retains four temperature probe interfaces, ensuring no compromise in functionality despite the weight reduction. The time required to reach the minimum temperature of -196°C is significantly shorter compared to the 3rd-generation Combosword™, and further optimization of the working fluid system has nearly doubled its operational endurance. This product is poised to become a practical, high-end medical device for physicians in thoracic surgery, hepatobiliary surgery, and breast and thyroid surgery, facilitating the treatment of early-stage lung cancer, liver cancer, breast cancer, and other conditions.

ELF™ Hybrid Cryo-Thermal Ablation System

The second new product, the EXCEED™ Tumor Microwave Ablation System, features a fully digital operating system with functions such as automatic consumable specification recognition, safety limits for ablation parameters, and simulated thermal field parameters. It also incorporates optimized designs including a high-precision peristaltic pump, detachable connection cables, multiple temperature monitoring channels, and various interaction methods. The ablation needles are available in sizes as fine as 18G (1.3mm) to meet diverse clinical needs. A full-needle water-cooling design minimizes tissue carbonization and adhesion. The HS series ensures round ablation zones to enhance the precision of the ablation range, while the HT series’ multi-point temperature monitoring function further improves the controllability of the ablation area.

It is reported that this product is the first microwave ablation device in Beijing and one of the few high-end medical devices in China to have received dual certification from both the NMPA and the FDA. It also boasts several industry-first advantages, including three efficient operation modes, real-time dynamic adjustment of ablation prediction heatmaps during rotation, and an interface for a four-point stereoscopic temperature-sensing needle.

EXCEED™ Tumor Microwave Ablation System

EASYSOLV™ AI Ablation Surgical Planning System. With the rapid advancement of artificial intelligence technology, the healthcare industry is undergoing a transformation. Hygea’s EASYSOLV™ AI Ablation Surgical Planning System integrates artificial intelligence, medical image processing, and surgical simulation technologies to provide efficient and precise surgical solutions for physicians and patients. Leveraging cutting-edge deep learning algorithms, the system achieves a 3D segmentation accuracy of 0.98, faithfully reconstructing tissue morphology. It enables 3D reconstruction of all thoracic and abdominal tissues, bones, and blood vessels, while supporting both 3D and Multi-Planar Reconstruction (MPR) viewing modes. As a global first, its fully automatic path planning function employs a multi-constraint intelligent collaborative algorithm that comprehensively considers tumor characteristics and surrounding structures to automatically determine the optimal ablation needle trajectory, thereby enhancing surgical precision and reducing risks. Its pioneering ablation field simulation feature further ensures greater ablation accuracy.

EASYSOLV™ AI Ablation Surgical Planning System

From breaking technological monopolies and achieving original innovation to leading and integrating innovation, Hygea’s journey serves as a microcosm of China’s innovative medical enterprises. As more indigenous Chinese technologies emerge, Chinese solutions and high-end intelligent medical manufacturing will experience explosive growth, accelerating the pace of import substitution.